Advanced Photonix, Inc. Announces Pricing Of Public Offering Of Common Stock
May 30, 2014
ANN ARBOR, Mich. -- Advanced Photonix, Inc.® (NYSE MKT: API) announced today that it priced an underwritten public offering of 5,391,304 shares of its Class A Common Stock at a public offering of $0.53 a share. Additionally, the Company has granted the underwriter an option exercisable for a 30-day period to the purchase up to [...]
Brooks Automation Closes Sale of Granville-Phillips to MKS Instruments
May 30, 2014
CHELMSFORD, Mass.-- Brooks Automation, Inc. (Nasdaq:BRKS) today announced that it has closed the sale of its Granville-Phillips instrumentation business, based in Longmont, CO, to MKS Instruments, Inc., headquartered in Andover, MA, for $87 million in cash. Granville-Phillips was founded in 1954, acquired by Helix Technology in 1998 and became part of Brooks through its merger [...]
May 30, 2014
San Diego, Calif. –– Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc. (NASDAQ:SQNM), which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories. Agena Bioscience has retained the employees of the acquired segment and will remain headquartered [...]
May 30, 2014
New York, NY -- Enzo Biochem, Inc. (NYSE:ENZ), a vertically integrated biosciences and clinical laboratory company, announced today that its Life Sciences division has established a collaboration with Innate Pharma S.A. to support a novel application of its ProteoStat® products for antibody-drug conjugate (ADC) design. ADCs are monoclonal antibodies engineered to go unnoticed, delivering cytotoxic [...]
May 30, 2014
GLOSTRUP, Denmark -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced a collaboration with Merck & Co., Inc. (known as MSD outside the United States and Canada, through an affiliate) to develop a companion diagnostic test for the analysis of the potential tumor biomarker PD-L1 to aid in the [...]
May 29, 2014
ST. GEORGE, Utah and PALO ALTO, Calif. -- Intermountain Healthcare (an internationally recognized not-for-profit system of 22 hospitals, a medical group with over 185 physician clinics, and an affiliated health insurance company) and Syapse (the leading provider of software for bringing omics data into routine medical use) announced today a collaboration to bring genomics-driven precision [...]
Agilent Technologies Announces Support for Women in Science, Engineering and Technology in Korea
May 29, 2014
SANTA CLARA, Calif. -– Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with the Center for Women in Science, Engineering and Technology (WISET), a government organization based in Seoul to help advance women scientists and engineers in South Korea. Under the agreement, Agilent and WISET will jointly develop training programs that will be [...]
Flowmi™ Cell Strainers Quickly and Efficiently Remove the Junk from Flow and FACS Samples
May 29, 2014
Wayne, NJ -- Flowmi™ Cell Strainers may revolutionize how researchers process small volume samples (less than 1000µl) for Flow Cytometer (FLOW) and Fluorescence-Assisted Cell Sorting (FACS*) analysis. These new, patent pending cell strainers by Bel-Art Products provide efficient filtering with minimal sample loss while reducing the risk of cytometer clogs. “Until now there was no [...]
Remedy Informatics Welcomes Dr. Scott Howard as New Chief Medical Officer
May 29, 2014
SALT LAKE CITY –– Remedy Informatics, the leading provider of registry-based clinical informatics software for healthcare delivery and life sciences research, announced today that Scott C. Howard, MD, MSc, will join the company’s executive team as Chief Medical Officer (CMO). Dr. Howard comes to Remedy from St. Jude Children’s Research Hospital where he was a [...]
New Kits, Proteins, and Screening Services for Immunotherapy Drug Discovery from BPS Bioscience
May 29, 2014
San Diego, CA -- Immunotherapy is defined as the treatment of disease by inducing, enhancing, or suppressing an immune response. Based on the “two signal” model, most immunotherapies regulate the immune response by targeting the co-stimulatory or co-inhibitory pathways of immune activation. These T-cell co-signaling proteins include members of the CD28:B7-1, CTLA4:B7-1, BTLA:HVEM, PD-1:PDL1 and [...]
